Strong launch for Cresemba in Japan triggers first sales milestone payment from AKP to Basilea
Allschwil, Switzerland, February 05, 2025 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a…
Basilea is awarded additional CARB-X funding to develop new drug candidate from a novel class of antibiotics
Additional funding awarded following successful drug candidate nominationUSD 7.3 million to support…